DMAE is a choline-like molecule used as an oral supplement for thinking, mood, and cellular aging, and applied to skin for firmness. Its best-supported use is cosmetic skin firming, backed by small controlled studies, though the effect is modest and somewhat short-lived. Evidence for mental, mood, and aging claims is weak or limited to animal work.
(Full Review)
Risk & Side Effects
- High: [risks_high]
- Medium: Mild gastrointestinal and stimulant-like effects; topical skin irritation
- Low: Worsening of seizure or movement disorders; hypomania or agitation in mood-disorder-prone individuals
- Speculative: Reproductive and developmental concerns; long-term cellular effects of chronic use
Monitoring
| Marker |
Target |
Why |
|
Homocysteine
|
5–7 µmol/L
|
Reflects one-carbon/methylation status that DMAE feeds into
|
|
Plasma/serum choline
|
Within normal lab reference range
|
Provides context on baseline cholinergic substrate
|
|
Folate and Vitamin B12
|
Folate upper-normal; B12 >500 pg/mL
|
Support the methylation pathways DMAE interacts with
|
Cadence:
Reassess subjective response and tolerability at ~2 weeks and 6–8 weeks, then every 3–6 months if continued.
Qualitative Assessment
-
Cognitive clarity and focus: whether sustained attention or mental sharpness improves noticeably
-
Mood and alertness: whether mood, motivation, or daytime alertness shifts favorably without overstimulation
-
Sleep quality: whether sleep remains intact, as a sign the dose and timing are appropriate
-
Skin firmness and tone (topical): whether facial firmness and the appearance of fine lines visibly improve over weeks
-
Side-effect burden: whether headache, gastrointestinal upset, irritability, or skin irritation remain absent or minimal